A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)

NCT01286818 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Carcinoma

Interventions

BIOLOGICAL: Ramucirumab (IMC-1121B)
DRUG: Irinotecan
DRUG: levofolinate
DRUG: 5-Fluorouracil (5-FU)

Sponsor

Eli Lilly and Company